Bautista, Ermenido F.
HRN: 25-06-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2024
05/29/2024
IV
4.5g
Q6H
CMBO; S/P Exlap
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes